Your browser doesn't support javascript.
loading
The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).
Font, Albert; Luque, Raquel; Villa, José Carlos; Domenech, Montse; Vázquez, Sergio; Gallardo, Enrique; Virizuela, Juan Antonio; Beato, Carmen; Morales-Barrera, Rafael; Gelabert, Antoni; Maciá, Sonia; Puente, Javier; Rubio, Gustavo; Maldonado, Xavier; Perez-Valderrama, Begoña; Pinto, Alvaro; Fernández Calvo, Ovidio; Grande, Enrique; Garde-Noguera, Javier; Fernández-Parra, Eva; Arranz, José Ángel.
Afiliação
  • Font A; Medical Oncology Service, B-ARGO Group, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Ctra Canyet, s/n, 08916, Badalona, Spain. afont@iconcologia.net.
  • Luque R; Medical Oncology Service, H.U. Virgen de las Nieves, Granada, Spain.
  • Villa JC; Medical Oncology Service, Hospital General Universitario Ciudad Real, Ciudad Real, Spain.
  • Domenech M; Medical Oncology Service, Hospital Fundació Althaia, Manresa, Spain.
  • Vázquez S; Medical Oncology Service, Hospital Universitario Lucus Augusti, EOXI de Lugo, Cervo e Monforte, Spain.
  • Gallardo E; Oncology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.
  • Virizuela JA; Medical Oncology Service, Hospital Virgen de la Macarena, Seville, Spain.
  • Beato C; Medical Oncology Service, Hospital Virgen de la Macarena, Seville, Spain.
  • Morales-Barrera R; Medical Oncology Service, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Gelabert A; Urology Department, Hospital del Mar, Barcelona, Spain.
  • Maciá S; Medical Oncology Department, CRO Pivotal, Madrid, Spain.
  • Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.
  • Rubio G; Medical Oncology Service, Hospital Universitario Fundación Jimenez Diaz, Madrid, Spain.
  • Maldonado X; Radiation Oncology Service, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Perez-Valderrama B; Medical Oncology Service, Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Pinto A; Medical Oncology Service, Hospital Universitario La Paz, Madrid, Spain.
  • Fernández Calvo O; Medical Oncology Service, Complejo Hospitalario Universitario Ourense, Orense, Spain.
  • Grande E; Medical Oncology, MD Anderson Cancer Center, Madrid, Spain.
  • Garde-Noguera J; Medical Oncology Service, Hospital Arnau de Vilanova, Valencia, Spain.
  • Fernández-Parra E; Medical Oncology Service, Hospital Universitario Nuestra Señora de Valme, Seville, Spain.
  • Arranz JÁ; Medical Oncology Service, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
Target Oncol ; 14(1): 15-32, 2019 02.
Article em En | MEDLINE | ID: mdl-30694442
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Urológicas / Terapia de Alvo Molecular Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Urológicas / Terapia de Alvo Molecular Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha